HCA Healthcare (NYSE:HCA – Free Report) had its target price reduced by KeyCorp from $420.00 to $370.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have an overweight rating on the stock.
A number of other research analysts also recently weighed in on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Barclays decreased their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $385.27.
View Our Latest Analysis on HCA
HCA Healthcare Trading Up 1.0 %
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.85%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio is 11.85%.
Insider Buying and Selling at HCA Healthcare
In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in HCA. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the third quarter worth approximately $39,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the 3rd quarter valued at $41,000. Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the second quarter valued at $33,000. Canoe Financial LP acquired a new stake in HCA Healthcare in the third quarter worth about $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in HCA Healthcare during the 3rd quarter valued at about $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- What is Forex and How Does it Work?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- ETF Screener: Uses and Step-by-Step Guide
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Industrial Products Stocks Investing
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.